Clinical Trial Results . org Drug-Eluting Stents in AMI (RCTs) M Leon, TCT 2006 M Leon, TCT 2006 Trial Trial DES DES BMS BMS N N Angio Follow- Angio Follow- Up Up Primary EP Primary EP STRATEGY STRATEGY 1 Cypher Cypher Bx Vel Bx Vel 175 175 Yes Yes 8 mo D, ReMI, 8 mo D, ReMI, CVA, or TVR CVA, or TVR TYPHOON TYPHOON 2 Cypher Cypher Any Any 700 700 Yes Yes 12 mo TVF 12 mo TVF SESAMI SESAMI 3 Cypher Cypher Bx Vel Bx Vel 320 320 Yes Yes 12 mo 12 mo restenosis restenosis PASSION PASSION 4 Taxus Taxus Exp Exp 2 / / Lib Lib 620 620 No No 12 mo D, 12 mo D, ReMI, TVR ReMI, TVR 1. 1. Valgimigli M et al. JAMA 2005; 293:2109-2117. Valgimigli M et al. JAMA 2005; 293:2109-2117. 2. Spaulding C et al. NEJM 2006; 2. Spaulding C et al. NEJM 2006; 355:1093-104. 355:1093-104. 3. Menichelli M. EuroPCR 2006. 3. Menichelli M. EuroPCR 2006. 4. Laarman GJ et al. NEJM 2006; 355:1105-13. 4. Laarman GJ et al. NEJM 2006; 355:1105-13.
Drug-Eluting Stents in AMI (RCTs). Valgimigli M et al. JAMA 2005; 293:2109-2117.2. Spaulding C et al. NEJM 2006; 355:1093-104. 3. Menichelli M. EuroPCR 2006. 4. Laarman GJ et al. NEJM 2006; 355:1105-13. M Leon, TCT 2006. Drug-eluting Stents in AMI (RCTs) Mortality. All p=NS. %. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Drug-Eluting Stents in AMI (RCTs)Drug-Eluting Stents in AMI (RCTs)
M Leon, TCT 2006M Leon, TCT 2006M Leon, TCT 2006M Leon, TCT 2006
TrialTrial DESDES BMSBMS NN Angio Follow-UpAngio Follow-Up Primary EPPrimary EP
STRATEGYSTRATEGY11 CypherCypher Bx VelBx Vel 175175 YesYes8 mo D, ReMI, 8 mo D, ReMI, CVA, or TVRCVA, or TVR
TYPHOONTYPHOON22 CypherCypher AnyAny 700700 Yes Yes 12 mo TVF12 mo TVF
SESAMISESAMI33 CypherCypher Bx VelBx Vel 320320 Yes Yes 12 mo 12 mo restenosisrestenosis
PASSIONPASSION44 TaxusTaxus ExpExp22/Lib/Lib 620620 NoNo 12 mo D, ReMI, 12 mo D, ReMI, TVRTVR
1.1. Valgimigli M et al. JAMA 2005; 293:2109-2117.Valgimigli M et al. JAMA 2005; 293:2109-2117. 2. Spaulding C et al. NEJM 2006; 355:1093-104.2. Spaulding C et al. NEJM 2006; 355:1093-104.
3. Menichelli M. EuroPCR 2006. 3. Menichelli M. EuroPCR 2006. 4. Laarman GJ et al. NEJM 2006; 355:1105-13.4. Laarman GJ et al. NEJM 2006; 355:1105-13.
1.1. Valgimigli M et al. JAMA 2005; 293:2109-2117.Valgimigli M et al. JAMA 2005; 293:2109-2117. 2. Spaulding C et al. NEJM 2006; 355:1093-104.2. Spaulding C et al. NEJM 2006; 355:1093-104.
3. Menichelli M. EuroPCR 2006. 3. Menichelli M. EuroPCR 2006. 4. Laarman GJ et al. NEJM 2006; 355:1105-13.4. Laarman GJ et al. NEJM 2006; 355:1105-13.